HEALTHCARE staff should double check patients who believe they are allergic to penicillin to reduce the risk of MRSA or C difficile, NICE has warned.
Evidence suggests around 10 per cent of the UK population has a penicillin allergy documented in their clinical notes, but only around five per cent of these people actually have a “true” penicillin allergy.
Those with a suspected allergy are more likely to be given broad-spectrum antibiotics which can put them at increased risk of developing MRSA and C difficile. It can also contribute to antimicrobial resistance.
New research by NICE found those noted as having a penicillin allergy – correctly or not – are almost 70 per cent more likely to develop the so-called hospital superbug MRSA. The study of nearly 300,000 patient records found they are also around 25 per cent more likely to develop C difficile.
NICE is urging health staff to ensure only bona fide penicillin allergies are recorded, in line with their guidance Drug allergy: diagnosis and management. It is also calling for responsible antibiotics prescribing in line with their guidance.
NICE deputy chief executive Professor Gillian Leng said: “Lots of people think they are allergic to penicillin because it gave them a rash when they were a child, their mum or dad told them they were allergic and it has stayed in their notes for decades. That is a very different thing to having a true penicillin allergy, which can result in a life-threatening anaphylactic reaction.
“If healthcare staff use NICE guidance to distinguish properly between the two, that could help stop the spread of both MRSA and antimicrobial resistance.”
This page was correct at the time of publication. Any guidance is intended as general guidance for members only. If you are a member and need specific advice relating to your own circumstances, please contact one of our advisers.